within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M02A_TopicalProductsForJointAndMuscularPain.M02AA14_Fentiazac;

model Fentiazac
  extends Pharmacolibrary.Drugs.ATC.M.M02AA14;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>M02AA14</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Fentiazac is a non-steroidal anti-inflammatory drug (NSAID) of the fenamate group. It was primarily investigated for its analgesic and anti-inflammatory properties, however it is not widely approved or marketed today and is not in clinical use.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters based on chemical similarity to other fenamates (such as mefenamic acid) in typical healthy adult population; no direct human pharmacokinetic studies found for fentiazac.</p><h4>References</h4><ol><li><p>Dowell, PS, et al., &amp; Whiteland, H (1984). The pharmacokinetics of fentiazac and its metabolite, p-hydroxyfentiazac, after twice-daily oral administration to male volunteers. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 14(12) 947–953. DOI:<a href=\"https://doi.org/10.3109/00498258409151493\">10.3109/00498258409151493</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6531942/\">https://pubmed.ncbi.nlm.nih.gov/6531942</a></p></li><li><p>Quattrini, M, et al., &amp; Silvestri, S (1981). Serum and urinary levels of fentiazac after a single oral and epicutaneous administration in human subjects. <i>Arzneimittel-Forschung</i> 31(6) 1046–1048. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7196238/\">https://pubmed.ncbi.nlm.nih.gov/7196238</a></p></li><li><p>Franklin, RA, et al., &amp; Rhenius, ST (1984). Preliminary studies on the fate of 14C-fentiazac in man. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 14(12) 956–960. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6531943/\">https://pubmed.ncbi.nlm.nih.gov/6531943</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Fentiazac;
